Abstract
Menopause and essential hypertension are associated with a decreased compliance and distensibility of the arteries. ACE inhibitors have been shown to improve arterial distensibility. Hormone replacement therapy (HRT), especially estrogens, could have a positive influence through their atheroprotective, vasodilative, and blood pressure–lowering effect. The vascular interactions of HRT and ACE inhibitors, like moexipril hydrochloride, have not been investigated so far. This trial was intended to assess the effect of combined sequential HRT for 25 days on acute changes in arterial distensibility after a single oral dose of 15 mg moexipril hydrochloride in postmenopausal women with borderline to mild essential hypertension. This study had a monocentric, randomized, parallel-group design, and was open for moexipril, and double-blind, and placebo-controlled for HRT. Assessment of arterial distensibility was by automatic noninvasive measurement of the carotid–femoral pulse wave velocity (PWV). The PWV and the pulse pressure decreased significantly after a single oral dose of 15 mg moexipril. An influence of HRT on the changes in the PWV and pulse pressure could not be seen. The plasma concentrations of renin increased and of aldosterone decreased after moexipril administration. Arterial function improves after acute administration of 15 mg moexipril in postmenopausal women with mild to moderate essential hypertension. The changes in PWV and pulse pressure are of similar magnitude in women with and without HRT.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Rajkumar C, Kingwell BA, Cameron JD, Waddel T, Mehra R, Christophidis N, Komesaroff PA, McGrath B, Jennings GL, Sudhir K, Dart AM. Hormonal therapy increases arterial compliance in postmenauposal women. J Am Coll Cardiol 1997;30:350-356.
Taddei S, Virdis A, Ghiadoni L, Mattei P, Sudano I, Bernini G, Pinto S, Salvetti A. Menopause is associated with endothelial dysfunction in women. Hypertension 1996;28:576-582.
London GM, Guerin AP, Pannier B, Marchais SJ, Benetos A, Safar ME. Influence of sex on arterial hemodynamics and blood pressure. Role of body height. Hypertension 1995;26: 514-519.
Wolinski H. Effects of estrogen and progesterone treatment on the response of the aorta of male rats to hypertension. Morphological and chemical studies. Circ Res 1972;30:341-394.
Fischer GM. In vivo effects of estradiol on collagen and elastin dynamics in rat aorta. Endocrinology 1972;91:1227-1232.
Safar ME, Asmar RG, Benetos A. Large artery dilation produced by converting enzyme inhibition in hypertension: Therapeutic aspects. Am J Med 1992;92(Suppl. 4B):47-53.
Safar ME. Antihypertensive effects of nitrates in chronic human hypertension. J Appl Cardiol 1990;5:69-81.
Darne BE, Girerd X, Safar M, Cambien F, Guize L. Pulsatile versus steady component of blood pressure: A cross-sectional analysis and a prospective analysis on cardiovascular mortality. Hypertension 1989;13:392-400.
Safar ME, Levy BI, Laurent ST, London GM, Hypertension and the arterial system: Clinical and therapeutic aspects. J Hypertens 1990;8(Suppl. 7):S113-S119.
Stimpel M, Cawello W. Pharmacokinetics and ACE-inhibition of the new ACE-inhibitor moexipril: Is coadministration with food of clinical relevance? Hypertension 1995;26: 1384-1396.
Stimpel M, Koch B. Moexipril versus placebo in postmenopausal women receiving HRT. Hypertension 1997;29: 843-851.
Stimpel M, Bonn R, Koch B, Dickstein K. Pharmacology and clinical use of the new ACE-inhibitor moexipril. Cardiovasc Drug Rev 1995;13:211-229.
Edling O, Bao G, Feelisch M, Unger T, Gohlke P. Moexipril, a new angiotensin converting enzyme (ACE) inhibitor: Pharmacological characterization and comparison with enalapril. J Pharmacol Exp Ther 1995;275:854-863.
White WB, Whelton A, Fox AAL, Stimpel M, Kaihlanen PM. Tricenter assessment of the efficacy and pharmacodynamics of the ACE-inhibitor, moexipril, by ambulatory blood pressure monitoring. J Clin Pharmacol 1995;35:233-238.
Koch B, Stimpel M, Andersson O. Low-dose combinations of moexipril and hydrochlorothiazide in the treatment of hypertension. Pharmacol Res 1995;31(Suppl.):328-337.
Asmar RG, Benetos A, Topouchian J, et al. Assessment of arterial compliance by automatic PWV measurements. Validation and clinical application studies. Hypertension 1995; 26:485-490.
Asmar RG, Benetos A, Darne BM, Pauly NC, Safar ME. Converting enzyme inhibition: Dissociation between antihypertensive and arterial effects. J Hum Hypertens 1992;6: 381-385.
Scalbert E, Levy B, Desche P, Devissaguet M, Safar ME. Vascular effects of perindopril: From experimental to clinical investigation. J Cardiovasc Pharmacol 1991;18(Suppl. 7):S25-S32.
Asmar RG, Iannascoli F, Benetos A, Safar ME. Dose optimization study of arterial changes associated with angiotensin converting inhibition in hypertension. J Hypertens 1992;10(Suppl. 5): S13-S19.
Benetos A, Vasmant D, Thiery P, Safar ME. Effects of ramipril on arterial hemodynamics. J Cardiovasc Pharmacol 1991;18(Suppl. 2):S153-S156.
London G, Courivaux JM, Stimpel M, Safar ME. Arterial stiffness and extracellular matrix in ovariectomized female spontaneously hypertensive rats. In: Stimpel M, Zanchetti A, eds. Hypertension After menopause. Berlin: de Gruyte, 1997:113-123.
Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol 1997;17: 3196-3201.
Pang SC, Greendale GA, Cedars MI, Gambone JC, Lozano K, Eggana P, Judd HL. Long term effects of transdermal estradiol with and without medroxyprogesterone acetate. Fertil Steril 1993;59:76-82.
The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on the heart disease risk factors in postmenopausal women. JAMA 1995;273:199-208.
Mendelsohn ME, Karas RH. Estrogen and the blood vessel wall. Curr Opin Cardiol 1994;9:619-626.
Schunkert H, Danser AHJ, Hense HW, Derkx FHM, Kürzinger S, Riegger GAG. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women. Circulation 1997;95:39-45.
Proudler AJ, Ahmed ALH, Crook D, Fogelman I, Rymer JM, Stevenson JC. Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women. Lancet 1995;346:89-90.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Blacher, J., Raison, J., Amah, G. et al. Increased Arterial Distensibility in Postmenopausal Hypertensive Women with and Without Hormone Replacement Therapy after Acute Administration of the Ace Inhibitor Moexipril. Cardiovasc Drugs Ther 12, 409–414 (1998). https://doi.org/10.1023/A:1007733103730
Issue Date:
DOI: https://doi.org/10.1023/A:1007733103730